Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
J Surg Oncol ; 121(7): 1148-1153, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32133665

ABSTRACT

BACKGROUND AND OBJECTIVES: Sarcopenia is associated with poor long-term outcomes in many gastrointestinal cancers, but its role in anal squamous cell carcinoma (ASCC) is not defined. We hypothesized that patients with sarcopenic ASCC experience worse long-term outcomes. METHODS: A retrospective review of patients with ASCC treated at an academic medical center from 2006 to 2017 was performed. Of 104 patients with ASCC, 64 underwent PET/computed tomography before chemoradiation and were included in the analysis. The skeletal muscle index was calculated as total L3 skeletal muscle divided by height squared. Sarcopenia thresholds were 52.4 cm2 /m2 for men and 38.5 cm2 /m2 for women. Cox regression analysis was performed to assess overall and progression-free survival. RESULTS: Twenty-five percent of the patients were sarcopenic (n = 16). Demographics were similar between groups. There was no difference in the clinical stage or comorbidities between groups. On multivariate analysis, factors associated with worse overall survival were male gender (hazard ratio [HR] 3.7, P = .022) and sarcopenia (HR 3.6, P = .019). Male gender was associated with worse progression-free survival (HR 2.6, P = .016). CONCLUSIONS: Sarcopenia is associated with worse overall survival in patients with anal cancer. Further studies are indicated to determine if survival can be improved with increased attention to nutritional status in sarcopenic patients.


Subject(s)
Anus Neoplasms/mortality , Carcinoma, Squamous Cell/mortality , Sarcopenia/mortality , Anus Neoplasms/drug therapy , Anus Neoplasms/pathology , Anus Neoplasms/radiotherapy , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/radiotherapy , Female , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Neoplasm Staging , Prevalence , Progression-Free Survival , Retrospective Studies , Sarcopenia/pathology
2.
Indian J Radiol Imaging ; 29(2): 219-222, 2019.
Article in English | MEDLINE | ID: mdl-31367096

ABSTRACT

Congenital extrahepatic portosystemic shunt (CEPS) is a rare splanchnic venous malformation, wherein the portal venous outflow drains into the systemic venous circulation via a pathologic shunt. CEPS exhibits heterogeneous clinical behavior and angiography is the gold standard for evaluation of the portomesenteric communication to systemic vasculature. The potential severity of complications necessitates shunt closure. Here, we present two cases of CEPS. The first patient presented with an asymptomatic hyperammonemia and was found to have a Type 1 CEPS with absence of intrahepatic portal system. The second patient was asymptomatic and was incidentally found to have a Type 2 CEPS on imaging with normal intrahepatic portal system. Both patients were successfully treated with endovascular occlusion of the CEPS.

3.
Int J Cardiovasc Imaging ; 35(7): 1365-1377, 2019 Jul.
Article in English | MEDLINE | ID: mdl-30830527

ABSTRACT

Heart failure is a clinical condition that is associated with significant morbidity and mortality. With the advent of left ventricular assist device (LVAD), an increasing number of patients have received an artificial heart both as a bridge-to-therapy and as a destination therapy. Clinical trials have shown clear survival benefits of LVAD implantation. However, the increased survival benefits and improved quality of life come at the expense of an increased complication rate. Common complications include perioperative bleeding, infection, device thrombosis, gastrointestinal bleeding, right heart failure, and aortic hemodynamic changes. The LVAD-associated complications have unique pathophysiology. Multiple imaging modalities can be employed to investigate the complications, including computed tomography (CT), positron emission tomography-computed tomography (PET-CT), catheter angiography and echocardiography. Imaging studies not only help ascertain diagnosis and evaluate the severity of disease, but also help direct relevant clinical management and predict prognosis. In this article, we aim to review the common LVAD complications, present the associated imaging features and discuss the role of imaging in their management.


Subject(s)
Cardiac Imaging Techniques , Heart Failure/therapy , Heart-Assist Devices/adverse effects , Postoperative Complications/diagnostic imaging , Postoperative Complications/therapy , Prosthesis Implantation/adverse effects , Prosthesis Implantation/instrumentation , Ventricular Function, Left , Adult , Aged , Female , Heart Failure/diagnostic imaging , Heart Failure/physiopathology , Humans , Male , Middle Aged , Postoperative Complications/etiology , Predictive Value of Tests , Prosthesis Design , Risk Factors , Treatment Outcome
4.
J Ultrasound Med ; 38(10): 2541-2557, 2019 Oct.
Article in English | MEDLINE | ID: mdl-30714653

ABSTRACT

Since its introduction, contrast-enhanced ultrasound (CEUS) has gained an important role in the diagnosis and management of abdominal and pelvic diseases. Contrast-enhanced ultrasound can improve lesion detection rates as well as success rates of interventional procedures when compared to conventional ultrasound alone. Additionally, CEUS enables the interventionalist to assess the dynamic enhancement of different tissues and lesions, without the adverse effects of contrast-enhanced computed tomography, such as exposure to ionizing radiation and nephrotoxicity from iodinated contrast material. This review article describes the various applications and advantages of the use of CEUS to enhance performance of ultrasound-guided interventions in the abdomen and pelvis.


Subject(s)
Contrast Media , Digestive System Diseases/diagnostic imaging , Female Urogenital Diseases/diagnostic imaging , Image Enhancement/methods , Male Urogenital Diseases/diagnostic imaging , Splenic Diseases/diagnostic imaging , Ultrasonography, Interventional/methods , Abdomen/diagnostic imaging , Female , Humans , Male , Pelvis/diagnostic imaging
5.
Acad Radiol ; 25(12): 1617-1623, 2018 12.
Article in English | MEDLINE | ID: mdl-29573937

ABSTRACT

RATIONALE AND OBJECTIVES: To evaluate different techniques for reducing hemorrhagic complications in coagulopathic patients with elevated international normalized ratio having an image-guided percutaneous invasive procedure; techniques included systemic transfusion of fresh frozen plasma (FFP), local injection of FFP, percutaneous injection of gelatin sponge, and percutaneous placements of angiographic coils. MATERIALS AND METHODS: Retrospective review of 232 consecutive patients with known coagulopathy undergoing image-guided minimally invasive procedures were selected. Ninety-one patients had local FFP injected, 40 patients underwent local synthetic gelatin injection, 16 patients had percutaneous coil embolization, and 85 patients received systemic FFP. The number of bleeds, complications related to bleeds, and systemic complications were recorded. A 30 cc threshold was used to delineate significant bleeding. RESULTS: No patients experienced clinically significant or insignificant bleeding with local FFP injection (P value <.05). Other local hemostatic methods (Gelfoam, systemic FFP, and coil embolization) were associated with higher levels of bleeding (12.5%, 17.1%, 37.5%, respectively) and complications (7.5%, 31.4%, 37.5%, respectively). Systemic FFP infusion was associated with respiratory, infectious, and mortal complications. CONCLUSIONS: Local injection of blood products provides a safe and efficacious hemostatic agent to reduce the incidence of postprocedural bleeding. The technique is associated with lower rates of bleeding and systemic complications when compared to other local and systemic techniques. Further randomized prospective studies with a larger patient cohort need to be performed to corroborate these initial findings.


Subject(s)
Blood Loss, Surgical/prevention & control , Embolization, Therapeutic , Gelatin Sponge, Absorbable/therapeutic use , Hemostasis, Surgical/methods , Plasma , Postoperative Hemorrhage/prevention & control , Blood Coagulation Disorders/complications , Cohort Studies , Embolization, Therapeutic/adverse effects , Female , Gelatin Sponge, Absorbable/adverse effects , Hemostasis , Hemostasis, Surgical/adverse effects , Humans , International Normalized Ratio , Male , Middle Aged , Minimally Invasive Surgical Procedures/adverse effects , Platelet Transfusion , Retrospective Studies , Surgery, Computer-Assisted
6.
Int J Mol Med ; 31(5): 1153-8, 2013 May.
Article in English | MEDLINE | ID: mdl-23525250

ABSTRACT

The inhibition of elements of the plasminogen activator system [urokinase (uPA), tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1)] plays an important role in human diseases. PAI-1 is overexpressed in obesity and diabetes, and the inhibition of this protein has been postulated to alleviate the symptoms of both disorders. We found that two theaflavins (TFs) from black tea inhibit PAI-1 and we suggest that the beneficial effects of drinking tea may be associated with the suppression of PAI-1 activity by theaflavins. Epidemiological studies are controversial; some studies show the beneficial effects of drinking black tea on obesity and diabetes, while others do not. TFs, a family of compounds that can comprise up to 40% the dry weight of black tea, are responsible for the characteristic color, and they are known to chelate metals. We hypothesized that the content/variety of metals present in drinking water may be one of the reasons for such controversies in the population studies. TFs are excellent chelating compounds by trapping metals into complexes; thus, the quality of water used for tea preparation may influence changes in the formation of new products according to TF affinity for different metals, as well as their high molecular weight oxidation products. Our modeling and docking studies suggest that TF/metal complexes have similar affinity to PAI-1 as native TFs. However, analyses using liquid chromatography-mass spectroscopy (LC-MS) revealed the presence of TF degradation products in tea brewed using water containing metal salts. These can further form high molecular weight oxidation products. Thus, metals present in tea could diminish the beneficial effects of black tea by reducing TF concentration via metal-induced degradation and precipitation.


Subject(s)
Biflavonoids/pharmacology , Catechin/pharmacology , Coordination Complexes/pharmacology , Plasminogen Activator Inhibitor 1/metabolism , Biflavonoids/chemistry , Catechin/chemistry , Coordination Complexes/chemistry , Humans , Mass Spectrometry , Models, Molecular , Plasminogen Activator Inhibitor 1/chemistry , Protein Structure, Secondary , Tea/chemistry , Thermodynamics
7.
Arch Gynecol Obstet ; 286(1): 217-29, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22392488

ABSTRACT

PURPOSE: Our article reviews the evolving concepts in the field of male infertility for gynecologists and other health professionals involved in the care of men and women experiencing difficulty in having a child. The increased knowledge will help in the better management and treatment of infertile couples. METHODS: Review of literature through Pubmed, Science Direct, Online Library. RESULTS: Gynecologists are often the first healthcare providers to assess an infertile couple. Because half of all infertility problems stem from male factors, it is crucial for the gynecologist to remain updated on the main conditions that cause male infertility as well as current diagnostic tools and treatment options, including conventional strategies and assisted reproductive techniques. CONCLUSIONS: Extraordinary advances have been achieved in the field of male infertility over the past several years and many old concepts are now challenged. Therefore, it is imperative that male infertility physicians should update the gynecologists about the recent advances in the work-up of infertile men in terms of diagnosis and management. Such convention will help improve the standards of care for the infertile couple and enhance the cooperation between male and female reproductive endocrinologists.


Subject(s)
Infertility, Male/diagnosis , Infertility, Male/etiology , Antioxidants/therapeutic use , Azoospermia/etiology , Counseling , DNA Damage , Gynecology , Humans , Infertility, Male/drug therapy , Infertility, Male/genetics , Male , Medical History Taking , Reactive Oxygen Species/adverse effects , Semen Analysis , Varicocele/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...